ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1288

Dual Care Utilization in Patients Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry

Pascale Schwab1, Harlan Sayles2, Debra Bergman3, Grant W. Cannon4, Kaleb Michaud5, Ted R. Mikuls2 and Jennifer Barton1, 1VA Portland Health Care System, Portland, OR, 2University of Nebraska Medical Center, Omaha, NE, 3Rheumatology, University of Nebraska Medical Center, Omaha, NE, 4Division of Rheumatology, Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 5Rheumatology & Immunology, University of Nebraska Medical Center and National Data Base for Rheumatic Diseases, Omaha, NE

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Session Title: Health Services Research Poster II (ACR): Healthcare Access, Patterns of Medication Use and Workforce Considerations

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:   While use of multiple health
care systems may allow rapid access to medical care, the practice results in
fragmented and redundant treatments at a higher cost.  A common source of dual
care in the US is characterized by health care provided by both the Veterans
Affairs (VA) Healthcare System and any additional federal or private health care
coverage.  In a 2010 survey of VA enrollees, 75% of those 65 or older and 51%
of those under 65 received dual care. The objective of this study was to evaluate
dual care use by patients enrolled in the Veterans Affairs Rheumatoid Arthritis
Registry (VARA), a longitudinal multi-site disease registry and to compare
patient characteristics of dual users (DUs) and non-dual users (NDUs).

Methods:   A questionnaire based on the National Data
Bank for Rheumatic Diseases inquiring about dual care utilization was sent to veterans
with RA enrolled in VARA at 3 sites characterized by beneficiaries from both
urban and rural settings (Oregon, Nebraska, and Utah).  Veterans reported medical
services from a non-VA primary care provider or non-VA subspecialist.   Information
on co-morbidities, non-VA medications, and non-VA hospitalizations was also collected.
T-tests for continuous variables and Pearson chi-square tests for categorical
variables were performed to compare characteristics of DUs versus NDUs.  Fisher’s
exact test was used to compare comorbidities between the two groups.

Results:   Of 526 veterans surveyed, 310 (59%)
responded (74%, 69%, and 52% in Oregon, Nebraska, and Utah respectively).  Data
on the initial 251 responders are presented here.  Approximately one-fourth (26%)
of enrollees reported having a non-VA primary care physician, 22% reported
having a non-VA subspecialist (a third of these were cardiologists) and 5% reported
having a non-VA rheumatologist.  With respect to medication use, 24% of
respondents received non-VA non-RA medications and only 5% reported receiving a
non-VA synthetic DMARD, biologic DMARD, or corticosteroids. Overall, nearly 1 in
10 veterans had been hospitalized at a non-VA facility within 6 months prior to
the survey.  A comparison of patient characteristics revealed that DUs were
older, had more years of education, and were more likely to have never been
smokers compared to NDUs; additionally, DUs reported more comorbidities and
orthopedic procedures than NDUs (Table).

Conclusion:   VARA participants have a lower rate of
dual care utilization than previously reported for the overall VA population, with
very few patients receiving dual rheumatology care or non-VA RA medications.  This
survey suggests that the majority of US veterans enrolled in VARA utilize the VA
as their single source of RA care.  


Disclosure: P. Schwab, None; H. Sayles, None; D. Bergman, None; G. W. Cannon, Amgen, 2; K. Michaud, None; T. R. Mikuls, None; J. Barton, None.

To cite this abstract in AMA style:

Schwab P, Sayles H, Bergman D, Cannon GW, Michaud K, Mikuls TR, Barton J. Dual Care Utilization in Patients Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/dual-care-utilization-in-patients-enrolled-in-the-veterans-affairs-rheumatoid-arthritis-registry/. Accessed January 30, 2023.
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dual-care-utilization-in-patients-enrolled-in-the-veterans-affairs-rheumatoid-arthritis-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences